Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France.

Next Previous
Trial Profile

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Fulvestrant (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Sponsors AstraZeneca

    • Most Recent Events

    • 10 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top